MR Biophysics Lab

Buffalo Neuroimaging Analysis Center

Relationship Between Baseline Cognitive Performance and Brain Volume Outcomes in Patients With Relapsing Multiple Sclerosis in ENLIGHTEN: a Phase 3b Study of Ozanimod.

Conference paper

Zivadinov R, DeLuca, Riolo JV, Cheng C, Wray S, Bass A, Fox E, Riser E, Chaudhry B, Reardon J, Silva D, Naismith RT
Americas Committee for Treatment and Research in Multiple Sclerosis Forum, San Diego, CA, 2023
Cite

Cite

APA
R, Z., DeLuca, JV, R., C, C., S, W., A, B., … RT, N. (2023). Relationship Between Baseline Cognitive Performance and Brain Volume Outcomes in Patients With Relapsing Multiple Sclerosis in ENLIGHTEN: a Phase 3b Study of Ozanimod. San Diego, CA.

Chicago/Turabian
R, Zivadinov, DeLuca, Riolo JV, Cheng C, Wray S, Bass A, Fox E, et al. “Relationship Between Baseline Cognitive Performance and Brain Volume Outcomes in Patients With Relapsing Multiple Sclerosis in ENLIGHTEN: a Phase 3b Study of Ozanimod.” Americas Committee for Treatment and Research in Multiple Sclerosis Forum. San Diego, CA, 2023.

MLA
R, Zivadinov, et al. Relationship Between Baseline Cognitive Performance and Brain Volume Outcomes in Patients With Relapsing Multiple Sclerosis in ENLIGHTEN: a Phase 3b Study of Ozanimod. 2023.